We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Provexis Plc | LSE:PXS | London | Ordinary Share | GB00B0923P27 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0225 | -3.21% | 0.6775 | 0.605 | 0.795 | - | 636,008 | 16:35:30 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Food Preparations, Nec | 802k | -586k | -0.0003 | -23.33 | 15.52M |
Date | Subject | Author | Discuss |
---|---|---|---|
01/9/2023 20:18 | I am going in the middle wrt timescale here.It would probably take a >= 1 year if the pre submission work had not been as thorough but given the work that By-Health have done and that they have been working steadfastly toward this end i believe we are looking at 6 months to under a year. Once again this week we saw folks grasping at straws after the somewhat ambiguous rns trying to interpret it as tens of millions USD.We knew from before that originally the sum was in the ballpark of £1 million so with the extra trials that has grown to £2 million not tens of million gbp. What we dont know is the likelihood and quantum of extra funding that may be needed. Anyway it is good to know that the submission is underway at long last. Clearly By-Health are very keen on FF but again we have no idea what our margin is likely to be. My gut tells me it is likely to be several years before we can ascertain the scope of the deal with any real clarity - time for sales to build and profit to accrue to pxs. Not withstanding a price spike on news of product launch i suspect a lot of pi's will look to bail "early" and the price is likely to be volatile until it all settles down and revenues become more predictable. Hard to believe it has taken this long! | redprince | |
01/9/2023 19:11 | I’ve a feeling it won’t be that long , Davidxie posted on lse a couple of days ago , he doesn’t post very often but he seems to know what he’s talking about , I believe he lives in China but I might be wrong , gixer will probably put me right on that , I hope he doesn’t mind me putting his post on here. .... It is Yuan not Dollars, BH spent a few million pounds on Fruitflow since 2015. I have read the Implementation Rules document, it does not specify the time frame of approval, but given the work (pre-launch trials and report which are required by the Rules) done by BH, I expect it will be approved very soon and BH needs this to drive its growth. | winner31 | |
01/9/2023 12:21 | My guess, based on what we know about China and also, how long the EFSA took over here is that Henry won't be far out with an estimate of >=1 year. I'd be amazed if this took less than, say, six months, but, tbh, none of us really have a clue. We've got two hurdles to cross before knowing if this has taken Provexis into grown-up company land. 1. Getting a big tick in the box from SAMR 2. Seeing big enough orders for FF, along with a reasonable margin to make a material difference I don't think there's much risk of (1) not happening, so, for the first time in years, I've bought a few more. (2) is harder to call and will depend on what deal we've, presumably already agreed with By-Health and, longer term, how successful they are at selling it to consumers | bareknee | |
30/8/2023 17:39 | It seems to me that SAMR have been working closely with Byhealth on this application ,I think they want this to succeed almost as much as we do ! 246 / 5,000 Translation results Translation result Jimu News 23-8-31 12:01 From Weibo video account focus on [An optimistic industry with high prosperity, welcomes new favorable policies] The State Administration for Market Regulation has issued new regulations to liberalize the application for new functions of health food. Of course, applying for a new feature is not that easy. The new regulations emphasize that the evaluation indicators and criteria for new functions should be scientific, clear, feasible, and have been verified and evaluated. The first one to submit an application was BY-HEALTH, the leader in the dietary supplement industry. Taking "Qingluosin" as a breakthrough point, By-Health spent 8 years researching and finally submitted the application for a new function that "helps maintain normal platelet aggregation function and is beneficial to blood flow health", and its "scientific nutrition" strategic layout Go one step further. Jimu News’ Weibo video(Edited)Restore original | winner31 | |
30/8/2023 07:48 | Based on what we know wrt how slow the process has bee up to now, then i would say with no optimism whatsoever it will be at least 1 year God this is painful, never any timeframe, and they all continue to draw income I'm tempted to go to the agm this year, but they have become experts at delay. There is no incentive for them to act. Where is our salesforce ? I'm going to sell some more today if the share price rises anymore -plenty of time to buy back in on the retrace | horridhenry | |
30/8/2023 05:44 | I wouldn't say SAMR was particularly new as it was founded in 2018 by bringing together 3 separate agencies including the China Food and Drug Administration. What is new is the ability for companies to apply to SAMR (previously CFDA) to include new health function claims to the existing registrar. How long this new process will take is unknown but if By-Health have been working closely with the SAMR since 2015 then it could very well be a box ticking exercise. I live in hope anyway :) "The reason why BY-HEALTH was able to submit the innovation application at the first time was that BY-HEALTH had aimed at the new function of "maintaining normal platelet aggregation function" as early as 2015, and used Fruitflow, a water-soluble tomato concentrate known as "natural aspirin". ® (Hytonin), to carry out the research and development of the new function of maintaining normal platelet aggregation. The entire research and development lasted nearly eight years and invested tens of millions of funds." | gix er | |
29/8/2023 19:48 | Yes gixer - i just read that - very good indeed!However i agree with BB in that i think it will take some time for the regulatory guys to wade through the material particularly as SAMR is a new body and this is a novel claim. BWTFDIK! | redprince | |
29/8/2023 18:34 | I doubt it will be a drawn out process, as it says in That release they have already waited 8 years and spent millions getting to this stage , fingers crossed | winner31 | |
29/8/2023 17:54 | As By-Health are the first then its a bit of an unknown but lets hope it doesn't take that long. | gix er | |
29/8/2023 17:20 | I would imagine it'll take quite some time for the authorities to plough through all the documentation in the submission, but that's a big step in the right direction. | bareknee | |
29/8/2023 16:10 | redprince, "the trials are still on going and the SAMR process may not even have started yet." It all happened today. "On August 29, the second day after the "Implementation Rules" were officially implemented, BY-HEALTH, the industry leader, took the lead in submitting the application for the new function of health food "helping to maintain normal platelet aggregation function and beneficial to blood flow health", becoming The first company in the industry to submit new function declarations and product registration applications. The reason why BY-HEALTH was able to submit the innovation application at the first time was that BY-HEALTH had aimed at the new function of "maintaining normal platelet aggregation function" as early as 2015, and used Fruitflow, a water-soluble tomato concentrate known as "natural aspirin". ® (Hytonin), to carry out the research and development of the new function of maintaining normal platelet aggregation. The entire research and development lasted nearly eight years and invested tens of millions of funds." | gix er | |
29/8/2023 09:23 | Bloody hell, well, I didn't know that. | bareknee | |
29/8/2023 06:38 | Raymond John McKeeve was/is his name. Doubt he holds any shares in PXS anymore. Ocado might have been something to do with that. | gix er | |
28/8/2023 13:59 | Redprince Re "The many PIs" I doubt many PIs, who are long term holders have more than a few million shares each. According to a quick google search, the average volume of shares traded is roughly a million ( that was higher than I expected tbh ) With about 250 trading days a year and a free float of 1750 million that's a reasonable amount of the stock getting churned every year, which isn't really consistent with the idea of there being a large number of PIs who've invested a significant amount sitting patiently waiting for something to happen ? Admittedly the shares being churned won't be all of the free float, but it's still probably sensible to assume that, over the years, quite a lot of the "long-term holders" have quietly sold up and moved on ? Doubtless you'll know a few long-termers from the AGMs who are still around, but I suspect they're the exception rather than the rule. If you really want to influence things, you need to talk to Lucas. I understand your frustrations, but doing anything else is pretty much just fuming on the internet ... something I'm equally guilty of, and it can be good to spit it out, but it's basically farting into the wind :) | bareknee | |
28/8/2023 13:19 | BB - i think you ae perhaps confusing the largest shareholders with the many pi's who have (for them) invested a not insignifcant amount in here? McKeever was the lawyer - i tried contacting him years ago to no avail. No i have not tried to contact Lucas tbh although its always an option. Lucas clearly sees value here in the longer term although i am sure McKeever thought the same all those years ago! | redprince | |
28/8/2023 12:58 | Re "... and imo shareholder interest has often come second to those of the bod." Welcome to the world of loss making quoted companies RP, sadly, that's not uncommon. As far as major'ish shareholders over the years we've seen :- Moon selling his shares. DSM Venturing reducing their holding. Rising Stars selling up The lawyer who's name escapes me ( McKenna or something similar ? ) getting diluted below 3% and Lucas building a holding There's a few people on the boards who've said they've had fairly large holdings, but some of them have sold up or traded in and out a bit. The only person with a significant number of shares who has seemed interested in seeing the project through is Lucas, so, rightly or wrongly, your hope that shareholders would be, in the past, or will be in the future, interested in influencing the direction of travel is fundamentally flawed. If Lucas goes to the AGM, have you tried talking to him ? | bareknee | |
28/8/2023 08:10 | Absolutely gixer - the bb is for open discussion and you have been a great source of information about the company over the years. My frustration is about the way this company has been run for the last 14 years and imo shareholder interest has often come second to those of the bod. | redprince | |
28/8/2023 07:53 | redprince, No problem. We are all entitled to our opinions. Frankly IF being in Australia was never an issue for me and in some ways may even have been a benefit to us. Plenty of technology nowadays to allow you to work (in certain jobs) anywhere in the world. | gix er | |
27/8/2023 08:33 | Gixer - i have attended 3 agm's and the SIS meeting - i had to take flights for all of them. The rewards are out of kilter with the results and level at which this company has been operating at and it has cost us greatly in dilution. From SIS on it has been the death of a thousand cuts - Buck presided over all of this so in my view he should have been dismissed long ago. IF and Professor O'Kennedy got 17 millikon share options taking their total options to 55 million each on 23 January last year - the exercise price is 0.83 pence - that is far too low in my opinion. Wrt By-Health i understand why they did not launch when they originally planned to but my point is that this is always jam tomorrow and when the original announcement was made my gut feel was that it sounded too good to be true - and it was as 6 years on they still have not launced a meaningful product. IF relocated to Oz shortly after the demerger and this was not declared for years which i find particularly disengeneous - because it is.So it was hidden.He also tries to duck phonecalls from anyone who will challenge him and call him out on anything. We saw the planned substantial launch of MM shot format ditched because of lack of exclusivity by DSM - no one called them out on this.I asked about this policy at an agm but others choose to ignore it - this has cost us again. Shareholders have singularly failed to hold the board to account - anyone earning a six figure salary running a company like this should be held to account.Ford is not and every year he and Buck feed the faithful exactly what they want to hear and fob them off for another year. The pi's and apologists (like the fool on lse) have only themselves to blame. Not having a pop at you gixer but these are my genuine thoughts after 14 years in this company. | redprince | |
26/8/2023 18:33 | redprince, I can't comment on anything AGM as I have never attended one or indeed felt the need to go on a 800 mile round trip to hear what I already know as nothing can be said that hasn't already been released. But, and I know you wont like what I say, By-Health did launch a product, under the GymMax brand, sometime in 2018. Unfortunately it was only for the exclusive use of Chinese national athletes. Why a product wasn't released to the general population I don't know but the tightening of the regulations around that time might have been something to do with it and then the decision to go for Blue Cap and now a new health function claim. The SAMR process has indeed started but will not have been submitted yet. Hopefully By-Health will have everything in order once the Implementation Rules for New Functional Technology Evaluation of Health Foods are officially released. Although IF did not make it obvious that he was working from both the U.K. and Australia it certainly wasn't hidden and was reported in both the 2019 and 2020 annual results. | gix er | |
26/8/2023 08:23 | The fact that this circus has gone on for 14 years since gaining an EFSA approval and the shareholders have not demanded a clear road map or any other metric upon which to judge the bod's performance says we deserve all we get. Over those 14 years shareholder value has been destroyed almost completely,we have benn given the usual cut and paste drivel every year (same again at this years agm) and the faithful few turn up to be told what they want to hear at each agm and then tell the rest of us that this will be the year. By-Health were to luanch product by end of 2017 - the trials are still on going and the SAMR process may not even have started yet. IF hid in Australia for years and none of us knew! The agm will be full of paid flunkeys and attendees will have the pleasure of listening to the hapless Buck reading out the usual formalities.I pointed out years ago that he was useless and long after we got an RNS to confirm his uninspiring track record which was almost certainly forced by the largest shareholder. Still its all part of my education i suppose. | redprince | |
23/8/2023 17:00 | and for UK hxxps://www.blocked. | gix er | |
23/8/2023 16:57 | ADVFN didn't seem to like that link so try this one. | gix er | |
23/8/2023 16:54 | Same thing with both www.by-health.com (english) and www.by-health.com.cn (chinese)websites. They appear to be accessible within China [...] but not the UK except for a couple of ISP (Internet service providers) Hopefully its just a glitch and it comes back soon. | gix er | |
23/8/2023 11:27 | Gixer Me neither, doesn't make sense, Most of the sites blocked are to stop the Chinese using Western sites, but there are some the other way too. I wondered if it was a general anti-USA / Western thing on health and pharma, so I had a quick look at a few other similar Chinese companies sites and they all worked fine. It might just be that the non-Chinese By-Health website is broken and they don't know ! | bareknee |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions